122 related articles for article (PubMed ID: 9682981)
21. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas.
Oliveira DT; Sherriff M; Odell EW
J Oral Pathol Med; 1998 Aug; 27(7):303-7. PubMed ID: 9725567
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
23. The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Soost F; Löhrs U
Adv Exp Med Biol; 1998; 451():51-5. PubMed ID: 10026849
[No Abstract] [Full Text] [Related]
24. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
26. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
27. A loss of profilin-1 in late-stage oral squamous cell carcinoma.
Adami GR; O'Callaghan TN; Kolokythas A; Cabay RJ; Zhou Y; Schwartz JL
J Oral Pathol Med; 2017 Aug; 46(7):489-495. PubMed ID: 27862305
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
29. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of CD44 and CD133 expression in oral potentially malignant disorder and oral squamous cell carcinoma].
Jiajia Q; Yan S; Changqing Y; Wenjing J; Han Z; Yuanpan C; Qiuyan L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):311-316. PubMed ID: 28675018
[TBL] [Abstract][Full Text] [Related]
31. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells.
Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD
J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
33. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential.
Crowe DL; Milo GE; Shuler CF
J Dent Res; 1999 Jun; 78(6):1256-63. PubMed ID: 10371250
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells.
Sato S; Miyauchi M; Ogawa I; Kudo Y; Kitagawa S; Hiraoka M; Takata T
Oral Oncol; 2003 Jan; 39(1):27-30. PubMed ID: 12457718
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
36. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
37. [Expression and potential clinical significance of cytidine triphosphate: phosphocholine cytidylyltransferase-α in oral squamous cell carcinoma].
Lu FC; Xie XY; Yin XM; Gao YJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):254-258. PubMed ID: 29690696
[No Abstract] [Full Text] [Related]
38. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
39. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
